Empowered Diagnostics

Empowered Diagnostics delivers innovative, best-in-class diagnostic tests backed by leading experts in healthcare and biotechnology. Our mission is to empower people with the knowledge and confidence to understand their health through reliable, affordable, high-quality tests.

Empowered Diagnostics distinguishes itself with the following capabilities

One of the largest diagnostic manufacturing facilities in the USA, with a capacity of 1M TESTS PER DAY

Innovative, proprietary processes that deliver tests with improved accuracy, speed, and costs.

Novel rapid tests with INDUSTRY-LEADING PERFORMANCE.

The CovClear Rapid Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal swab specimens directly collected

Simple to use – Rapid Results in 3-20 Minutes

Highly Sensitive and Specific – Outperforming other antigen tests

Safety Advantage – Sealed Vial Protecting Collector Against Live Virus

No Reader Required – Reduced Cost

No Cassette Needed – Reduced Material Wastage

Early Detection – Reduced Exposure

Researched, developed & manufactured in the USA

CovClear has received CE marking for sale in the European Union.

NEUTRALIZING ANTIBODY RAPID TEST

Easy to Use

Rapid Results in 10 Minutes

Requires No Additional Equipment

Semiquantitative Results

ImmunoPass™ SARS-Cov-2 Neutralizing Antibody (NAb) Rapid Test is a rapid lateral flow chromatographic immunoassay intended for the semi-quantitative measurement of neutralizing antibodies in human serum or plasma (sodium heparin, potassium, and acid dextrose citrate).

The ImmunoPass™ SARS-Cov-2 Neutralizing Antibody (NAb) Rapid Test measures functional neutralizing antibodies (NAbs) within 10 minutes, unlike traditional tests which require days. The ImmunoPass™ test kit does not utilize live biological materials and does not require the strict biosafety protocol associated with live virus samples.

PERFORMANCE

100%

Sensitive

97.7%

Specific

IMMUNOPASS™ SCIENCE

The ImmunoPass™ Neutralizing Antibody (NAb) test demonstrates antibodies' ability to BLOCK the RBD's binding on spike protein to ACE2, the cellular receptor. RBD is the principal neutralizing determinant for SARS-CoV-2.

Why Are Neutralizing Antibodies Important?

NEUTRALIZING ANTIBODIESBLOCK the COVID virus, providing immunity protection against infection and re-infection

NEUTRALIZING ANTIBODIES inactivate the COVID-19 virus and are ASSOCIATED WITH IMMUNITY

NON-NEUTRALIZING ANTIBODIES do not block or neutralize COVID, thus do not protect re-infection.

How are Neutralizing Antibodies Measured?

The ImmunoPass™ Neutralizing Antibody tests measure titer levels, indicating the amount of neutralizing antibodies in a blood sample.

Titers are measured by ratios, where a higher ratio (1:320 compared to 1:8) indicates higher titer levels. A higher titer level means that the blood can be diluted many times and still produce a virus-neutralizing response.

Quality – Committed to the delivery of products and services of exceptional quality, exceeding the expectations of our customers, partners, and shareholders

Customer/Partner Focus – Dedication to our customer/partner expectations and ambitions through our decisions and actions

Professionalism – Unsurpassed scientific, technical, and business capabilities in service to our customers, partners, and employees

Integrity – Achieve the highest of ethical standards in all that we do

Performance – Excel at developing and providing innovative products and solutions, exceeding our commitments to all our stakeholders, partners, and customers

Environmental Responsibility – Competitive commercial-scale manufacturing in an environmentally sound manner